Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03282097 · ClinicalTrials.gov registry record · NA
Decisions About Cancer Screening in Alzheimer's Disease
A NA study of Alzheimer Disease and Cancer, Breast, sponsored by Indiana University.
- Completed
- Registry status
- NA
- Development phase
- 442
- Enrollment target
- 5
- Study locations
NCT03282097 is a NA study of Alzheimer Disease and Cancer, Breast that has completed, run by Indiana University. The registered enrollment target is 442 participants, below the 2,749-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (84% lower). The trial reports 5 study locations across 2 states.
The verdict
NCT03282097, a NA study of Alzheimer Disease and Cancer, Breast, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- NA
- Development phase
- 442 participants
- Enrollment target
- 5
- Study locations
Study Summary
The Decisions about Cancer screening in Alzheimer's Disease (DECAD) study tests if an evidence-based decision aid for dementia caregivers can support decision-making about mammography and improve the quality of medical decision-making about breast cancer screening. This large randomized controlled trial will recruit up to 450 dyads (900 individual participants) of older women with dementia and a family caregiver, for a goal of 426 dyad baselines (852 individual participants).
Conditions Studied
Interventions
- BEHAVIORAL DECAD decision aid
- OTHER Home safety guide
Study Locations (5)
Indiana
- Parkview Health - Fort Wayne
- Alzheimer's Association - Indianapolis
- Eskenazi Health - Indianapolis
- IU Health - Indianapolis
Massachusetts
- Beth Israel Deaconess Medical Center - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 442 participants |
| Start Date | 2017-12-01 |
| Est. Completion | 2024-07-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03282097
The ClinicalTrials.gov registry entry for NCT03282097 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 442 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,749-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (84% lower). The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Alzheimer Disease appearing as the primary indexed condition, and to 2 interventions - of which DECAD decision aid is the first listed.
NCT03282097 reports 5 study locations spanning 2 distinct geographic areas - top geographies include Indiana, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT03282097 about?
NCT03282097 is a clinical study titled "Decisions About Cancer Screening in Alzheimer's Disease". The Decisions about Cancer screening in Alzheimer's Disease (DECAD) study tests if an evidence-based decision aid for dementia caregivers can support decision-making about mammography and improve the quality of medical decision-making about breast cancer screening. This large randomized controlled t...
What is the current status of trial NCT03282097?
This trial is currently completed. It is a NA study. The enrollment target is 442 participants. The study started on 2017-12-01. Estimated completion is 2024-07-01.
What conditions does trial NCT03282097 study?
This clinical trial studies the following conditions: Alzheimer Disease, Cancer, Breast.
What interventions are being tested in trial NCT03282097?
The interventions under investigation include: DECAD decision aid (BEHAVIORAL), Home safety guide (OTHER).
Who is sponsoring clinical trial NCT03282097?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03282097 being conducted?
This trial has 5 study locations across Indiana, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alzheimer Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
I-CARE 2: Mobile Telehealth to Reduce Alzheimer'S-related Symptoms
RECRUITING · NA
-
Brain Outcomes With Lifestyle Change in Down Syndrome
RECRUITING · NA
-
Pulsed Electromagnetic Field Treatment In Patients With Alzheimer's Disease
RECRUITING · NA
-
A Feasiblity Study of Green Activity Program for People Living With Memory Challenges
RECRUITING · NA
-
Connect-Home: Alzheimer's Disease and Related Dementias
RECRUITING · NA
-
Cognitive Vulnerability to Stress in Individuals at Risk for Alzheimer's Disease
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.